Ali Musani
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchoscopy | 45 | 2023 | 246 | 12.300 |
Why?
| Pulmonary Medicine | 17 | 2023 | 87 | 7.630 |
Why?
| Lung Neoplasms | 15 | 2020 | 2199 | 2.280 |
Why?
| Certification | 4 | 2020 | 89 | 2.100 |
Why?
| Lung Diseases | 7 | 2019 | 696 | 1.960 |
Why?
| Pleural Effusion, Malignant | 6 | 2017 | 14 | 1.750 |
Why?
| Pulmonologists | 3 | 2023 | 16 | 1.710 |
Why?
| Pneumonectomy | 4 | 2020 | 125 | 1.650 |
Why?
| Photochemotherapy | 4 | 2020 | 29 | 1.500 |
Why?
| Endosonography | 6 | 2019 | 140 | 1.340 |
Why?
| Pleural Diseases | 4 | 2019 | 21 | 1.330 |
Why?
| Pulmonary Emphysema | 5 | 2020 | 268 | 1.200 |
Why?
| Societies, Medical | 6 | 2020 | 663 | 1.200 |
Why?
| Airway Obstruction | 7 | 2015 | 168 | 1.140 |
Why?
| Tracheal Stenosis | 5 | 2015 | 24 | 1.090 |
Why?
| Tracheobronchomalacia | 2 | 2018 | 14 | 1.020 |
Why?
| Stents | 9 | 2016 | 475 | 1.020 |
Why?
| Bronchi | 8 | 2018 | 232 | 1.010 |
Why?
| Tracheal Neoplasms | 2 | 2015 | 11 | 0.900 |
Why?
| Precancerous Conditions | 2 | 2015 | 158 | 0.890 |
Why?
| Bronchial Diseases | 2 | 2013 | 38 | 0.860 |
Why?
| Physician's Role | 2 | 2019 | 197 | 0.850 |
Why?
| Carcinoma, Non-Small-Cell Lung | 3 | 2020 | 973 | 0.810 |
Why?
| Tracheostomy | 4 | 2020 | 100 | 0.790 |
Why?
| Brachytherapy | 2 | 2020 | 104 | 0.750 |
Why?
| Humans | 73 | 2023 | 114756 | 0.720 |
Why?
| Rare Diseases | 2 | 2019 | 89 | 0.720 |
Why?
| Biopsy | 5 | 2019 | 1040 | 0.700 |
Why?
| Pulmonary Disease, Chronic Obstructive | 4 | 2019 | 916 | 0.690 |
Why?
| Eligibility Determination | 1 | 2020 | 60 | 0.690 |
Why?
| Foreign Bodies | 2 | 2018 | 96 | 0.680 |
Why?
| Lung | 8 | 2019 | 3546 | 0.680 |
Why?
| Pleurodesis | 4 | 2013 | 7 | 0.660 |
Why?
| Clinical Competence | 5 | 2020 | 896 | 0.660 |
Why?
| Thoracoscopy | 6 | 2019 | 53 | 0.650 |
Why?
| Cryosurgery | 2 | 2019 | 52 | 0.620 |
Why?
| Photosensitizing Agents | 2 | 2018 | 26 | 0.610 |
Why?
| Dihematoporphyrin Ether | 1 | 2018 | 3 | 0.610 |
Why?
| Radiology, Interventional | 1 | 2018 | 26 | 0.600 |
Why?
| Optical Imaging | 2 | 2015 | 54 | 0.600 |
Why?
| Ablation Techniques | 2 | 2019 | 29 | 0.600 |
Why?
| Cough | 1 | 2018 | 107 | 0.570 |
Why?
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 40 | 0.560 |
Why?
| Bronchoscopes | 2 | 2013 | 4 | 0.560 |
Why?
| Tracheal Diseases | 2 | 2016 | 15 | 0.550 |
Why?
| Prostheses and Implants | 2 | 2014 | 138 | 0.510 |
Why?
| Electromagnetic Phenomena | 2 | 2012 | 22 | 0.510 |
Why?
| Precision Medicine | 1 | 2019 | 338 | 0.500 |
Why?
| Bronchial Neoplasms | 1 | 2015 | 14 | 0.500 |
Why?
| Bronchial Fistula | 1 | 2015 | 4 | 0.500 |
Why?
| Respiratory Insufficiency | 2 | 2020 | 291 | 0.470 |
Why?
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 73 | 0.460 |
Why?
| Emphysema | 1 | 2014 | 107 | 0.440 |
Why?
| Light | 2 | 2015 | 336 | 0.430 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2013 | 133 | 0.420 |
Why?
| Tracheomalacia | 1 | 2012 | 19 | 0.420 |
Why?
| Endoscopy | 1 | 2015 | 248 | 0.410 |
Why?
| Solitary Pulmonary Nodule | 2 | 2012 | 20 | 0.410 |
Why?
| Mass Screening | 1 | 2019 | 1003 | 0.400 |
Why?
| Carcinoid Tumor | 1 | 2012 | 25 | 0.400 |
Why?
| Lung Diseases, Interstitial | 1 | 2017 | 507 | 0.390 |
Why?
| Esophageal Neoplasms | 1 | 2015 | 273 | 0.390 |
Why?
| Adenocarcinoma | 1 | 2018 | 801 | 0.380 |
Why?
| Paraganglioma | 1 | 2012 | 47 | 0.380 |
Why?
| Thoracentesis | 2 | 2022 | 8 | 0.380 |
Why?
| Kidney Neoplasms | 1 | 2015 | 333 | 0.370 |
Why?
| Drainage | 4 | 2017 | 151 | 0.370 |
Why?
| Epithelial Cells | 2 | 2015 | 955 | 0.360 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 21 | 0.350 |
Why?
| Catheters, Indwelling | 4 | 2017 | 79 | 0.350 |
Why?
| Primary Health Care | 1 | 2019 | 1515 | 0.330 |
Why?
| Colorectal Neoplasms | 1 | 2015 | 621 | 0.310 |
Why?
| Forced Expiratory Volume | 4 | 2020 | 476 | 0.310 |
Why?
| Tomography, X-Ray Computed | 8 | 2018 | 2269 | 0.300 |
Why?
| Ultrasonography, Interventional | 2 | 2022 | 123 | 0.300 |
Why?
| Correspondence as Topic | 1 | 2007 | 15 | 0.300 |
Why?
| Bereavement | 1 | 2007 | 49 | 0.290 |
Why?
| Betacoronavirus | 2 | 2020 | 252 | 0.290 |
Why?
| Treatment Outcome | 11 | 2020 | 9089 | 0.280 |
Why?
| Sensitivity and Specificity | 3 | 2017 | 1691 | 0.270 |
Why?
| Professional-Family Relations | 1 | 2007 | 133 | 0.270 |
Why?
| United States | 7 | 2023 | 12176 | 0.260 |
Why?
| Mediastinal Neoplasms | 1 | 2005 | 32 | 0.250 |
Why?
| Pneumonia, Viral | 2 | 2020 | 340 | 0.250 |
Why?
| Coronavirus Infections | 2 | 2020 | 332 | 0.250 |
Why?
| Educational Measurement | 2 | 2020 | 244 | 0.250 |
Why?
| Equipment Design | 4 | 2013 | 508 | 0.230 |
Why?
| Foreign-Body Migration | 2 | 2015 | 37 | 0.220 |
Why?
| Diagnosis, Differential | 4 | 2012 | 1340 | 0.220 |
Why?
| Catheterization, Peripheral | 1 | 2004 | 101 | 0.220 |
Why?
| Catheterization | 2 | 2019 | 160 | 0.210 |
Why?
| Neoplasm Staging | 3 | 2020 | 1176 | 0.210 |
Why?
| Intubation, Intratracheal | 2 | 2016 | 215 | 0.210 |
Why?
| Electrocoagulation | 2 | 2013 | 38 | 0.200 |
Why?
| Immunohistochemistry | 2 | 2019 | 1635 | 0.200 |
Why?
| Pneumonia | 3 | 2019 | 566 | 0.190 |
Why?
| Male | 19 | 2023 | 55579 | 0.190 |
Why?
| Biopsy, Needle | 2 | 2012 | 181 | 0.190 |
Why?
| Education, Medical, Graduate | 2 | 2017 | 370 | 0.190 |
Why?
| Climate Change | 1 | 2023 | 127 | 0.190 |
Why?
| Asthma | 6 | 2019 | 2032 | 0.190 |
Why?
| Network Meta-Analysis | 1 | 2020 | 15 | 0.180 |
Why?
| Ultrasonography | 2 | 2022 | 629 | 0.180 |
Why?
| Mediastinum | 1 | 2020 | 21 | 0.180 |
Why?
| Inventions | 1 | 2020 | 18 | 0.180 |
Why?
| Chronic Disease | 2 | 2018 | 1590 | 0.170 |
Why?
| Pathologists | 1 | 2019 | 15 | 0.170 |
Why?
| Education | 1 | 2020 | 95 | 0.170 |
Why?
| Bronchial Thermoplasty | 1 | 2019 | 1 | 0.170 |
Why?
| Specimen Handling | 1 | 2020 | 156 | 0.170 |
Why?
| Oncologists | 1 | 2019 | 31 | 0.170 |
Why?
| Bronchoalveolar Lavage Fluid | 4 | 2008 | 589 | 0.160 |
Why?
| Infection Control | 1 | 2020 | 135 | 0.160 |
Why?
| Female | 17 | 2023 | 59507 | 0.160 |
Why?
| Chest Tubes | 2 | 2009 | 30 | 0.160 |
Why?
| Image-Guided Biopsy | 1 | 2018 | 31 | 0.160 |
Why?
| Neoplasms | 2 | 2008 | 2105 | 0.150 |
Why?
| Community-Acquired Infections | 1 | 2019 | 141 | 0.140 |
Why?
| Logistic Models | 2 | 2012 | 1843 | 0.140 |
Why?
| Dogs | 1 | 2018 | 334 | 0.140 |
Why?
| Prognosis | 2 | 2019 | 3334 | 0.140 |
Why?
| Lung Volume Measurements | 2 | 2014 | 45 | 0.140 |
Why?
| Accreditation | 1 | 2017 | 76 | 0.140 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 440 | 0.140 |
Why?
| Fellowships and Scholarships | 2 | 2017 | 227 | 0.140 |
Why?
| Middle Aged | 11 | 2017 | 26757 | 0.130 |
Why?
| Iatrogenic Disease | 1 | 2016 | 49 | 0.130 |
Why?
| Radiography | 2 | 2012 | 811 | 0.130 |
Why?
| Tumor Burden | 1 | 2017 | 261 | 0.130 |
Why?
| Absorbable Implants | 1 | 2015 | 34 | 0.130 |
Why?
| Pandemics | 2 | 2020 | 1319 | 0.130 |
Why?
| Aged | 7 | 2016 | 19094 | 0.130 |
Why?
| Narrow Band Imaging | 1 | 2015 | 15 | 0.130 |
Why?
| Safety | 1 | 2017 | 297 | 0.130 |
Why?
| Intraoperative Complications | 1 | 2016 | 121 | 0.120 |
Why?
| Physicians | 1 | 2023 | 772 | 0.120 |
Why?
| Recurrence | 4 | 2017 | 936 | 0.120 |
Why?
| Collagen Type III | 3 | 2004 | 18 | 0.120 |
Why?
| Trachea | 1 | 2016 | 223 | 0.120 |
Why?
| Postoperative Complications | 2 | 2019 | 2127 | 0.120 |
Why?
| Bronchial Provocation Tests | 3 | 2004 | 53 | 0.120 |
Why?
| Adult | 12 | 2015 | 30548 | 0.110 |
Why?
| Lung Transplantation | 2 | 2014 | 246 | 0.110 |
Why?
| Fiber Optic Technology | 1 | 2013 | 19 | 0.110 |
Why?
| Device Removal | 2 | 2012 | 126 | 0.110 |
Why?
| Paracentesis | 1 | 2013 | 7 | 0.110 |
Why?
| Retrospective Studies | 6 | 2016 | 12515 | 0.110 |
Why?
| Cryotherapy | 1 | 2013 | 16 | 0.110 |
Why?
| Contraindications | 1 | 2013 | 85 | 0.110 |
Why?
| Metals | 1 | 2014 | 107 | 0.110 |
Why?
| Prosthesis Implantation | 1 | 2014 | 139 | 0.100 |
Why?
| Glaucoma Drainage Implants | 1 | 2013 | 47 | 0.100 |
Why?
| Exercise Tolerance | 1 | 2014 | 213 | 0.100 |
Why?
| Gastroscopy | 1 | 2012 | 18 | 0.100 |
Why?
| Silicones | 1 | 2012 | 20 | 0.100 |
Why?
| Laser Therapy | 1 | 2013 | 100 | 0.100 |
Why?
| Brain Abscess | 1 | 2012 | 11 | 0.100 |
Why?
| Hemoptysis | 1 | 2012 | 34 | 0.100 |
Why?
| Pulmonary Alveolar Proteinosis | 1 | 2012 | 16 | 0.100 |
Why?
| Genetic Therapy | 1 | 2013 | 257 | 0.100 |
Why?
| Time Factors | 4 | 2017 | 6124 | 0.100 |
Why?
| Lasers, Solid-State | 1 | 2011 | 22 | 0.100 |
Why?
| Respiratory Sounds | 1 | 2012 | 111 | 0.100 |
Why?
| Debridement | 1 | 2011 | 73 | 0.090 |
Why?
| Laryngoscopy | 1 | 2012 | 93 | 0.090 |
Why?
| Pulmonary Surgical Procedures | 1 | 2011 | 8 | 0.090 |
Why?
| Respiratory Tract Fistula | 1 | 2011 | 8 | 0.090 |
Why?
| Curriculum | 1 | 2017 | 825 | 0.090 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 134 | 0.090 |
Why?
| Exercise Therapy | 1 | 2014 | 351 | 0.090 |
Why?
| Recovery of Function | 1 | 2014 | 572 | 0.090 |
Why?
| Walking | 1 | 2014 | 422 | 0.090 |
Why?
| Surveys and Questionnaires | 3 | 2020 | 4625 | 0.090 |
Why?
| Fibroblasts | 3 | 2004 | 838 | 0.080 |
Why?
| Bronchial Hyperreactivity | 1 | 2010 | 95 | 0.080 |
Why?
| Follow-Up Studies | 3 | 2017 | 4420 | 0.080 |
Why?
| Sclerotherapy | 1 | 2009 | 19 | 0.080 |
Why?
| Pneumothorax | 1 | 2009 | 40 | 0.080 |
Why?
| Image Processing, Computer-Assisted | 1 | 2013 | 684 | 0.080 |
Why?
| Feasibility Studies | 1 | 2012 | 737 | 0.080 |
Why?
| Seizures | 1 | 2012 | 339 | 0.080 |
Why?
| Allergens | 2 | 2004 | 413 | 0.080 |
Why?
| Disease Models, Animal | 1 | 2018 | 3542 | 0.080 |
Why?
| Pleural Cavity | 1 | 2008 | 2 | 0.080 |
Why?
| Hypertension, Pulmonary | 1 | 2019 | 1728 | 0.080 |
Why?
| Pulmonary Alveoli | 1 | 2011 | 372 | 0.080 |
Why?
| Pulmonary Surfactant-Associated Protein D | 1 | 2008 | 29 | 0.080 |
Why?
| Faculty, Medical | 2 | 2023 | 228 | 0.070 |
Why?
| Aged, 80 and over | 2 | 2012 | 6350 | 0.070 |
Why?
| Forms and Records Control | 1 | 2007 | 22 | 0.070 |
Why?
| Steroids | 1 | 2008 | 145 | 0.070 |
Why?
| Incidence | 1 | 2013 | 2312 | 0.070 |
Why?
| Reimbursement Mechanisms | 1 | 2007 | 77 | 0.070 |
Why?
| Child | 2 | 2018 | 18352 | 0.070 |
Why?
| Granulation Tissue | 1 | 2006 | 6 | 0.070 |
Why?
| Patient Selection | 2 | 2020 | 641 | 0.070 |
Why?
| Empathy | 1 | 2007 | 138 | 0.070 |
Why?
| Cytosine | 1 | 2006 | 45 | 0.060 |
Why?
| Thymus Neoplasms | 1 | 2005 | 21 | 0.060 |
Why?
| Thymoma | 1 | 2005 | 30 | 0.060 |
Why?
| Muscle, Smooth | 2 | 2004 | 144 | 0.060 |
Why?
| Pediatrics | 1 | 2013 | 983 | 0.060 |
Why?
| Organophosphonates | 1 | 2006 | 91 | 0.060 |
Why?
| Prospective Studies | 2 | 2013 | 6217 | 0.060 |
Why?
| Teratoma | 1 | 2005 | 92 | 0.060 |
Why?
| Smoking | 1 | 2012 | 1384 | 0.060 |
Why?
| Lymphoma | 1 | 2005 | 177 | 0.060 |
Why?
| Actins | 2 | 2004 | 381 | 0.060 |
Why?
| Decision Support Techniques | 1 | 2007 | 351 | 0.060 |
Why?
| Interleukin-13 | 1 | 2004 | 122 | 0.050 |
Why?
| Transforming Growth Factors | 1 | 2003 | 3 | 0.050 |
Why?
| Interleukin-4 | 1 | 2004 | 208 | 0.050 |
Why?
| Risk Assessment | 1 | 2012 | 2973 | 0.050 |
Why?
| Zimbabwe | 1 | 2022 | 42 | 0.050 |
Why?
| Salaries and Fringe Benefits | 1 | 2023 | 52 | 0.050 |
Why?
| Thyroid Neoplasms | 1 | 2005 | 263 | 0.050 |
Why?
| Prosthesis Design | 2 | 2014 | 285 | 0.050 |
Why?
| Algorithms | 1 | 2009 | 1468 | 0.050 |
Why?
| Benchmarking | 1 | 2023 | 161 | 0.050 |
Why?
| Myofibrils | 1 | 2002 | 46 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2004 | 449 | 0.050 |
Why?
| Ambulatory Care | 1 | 2004 | 479 | 0.050 |
Why?
| Animals | 3 | 2018 | 31761 | 0.050 |
Why?
| Pollen | 1 | 2000 | 24 | 0.050 |
Why?
| Infant | 1 | 2013 | 7935 | 0.040 |
Why?
| Plant Proteins | 1 | 2000 | 81 | 0.040 |
Why?
| Clinical Protocols | 1 | 2020 | 232 | 0.040 |
Why?
| Interleukin-10 | 1 | 2000 | 296 | 0.040 |
Why?
| Qualitative Research | 1 | 2022 | 935 | 0.040 |
Why?
| Consensus | 1 | 2020 | 535 | 0.040 |
Why?
| Quality of Life | 3 | 2017 | 2358 | 0.040 |
Why?
| France | 1 | 2016 | 34 | 0.030 |
Why?
| Single-Blind Method | 1 | 2017 | 258 | 0.030 |
Why?
| Tracheoesophageal Fistula | 1 | 2016 | 32 | 0.030 |
Why?
| Airway Management | 1 | 2016 | 60 | 0.030 |
Why?
| Cytokines | 1 | 2003 | 1843 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2014 | 2539 | 0.030 |
Why?
| Oxygen | 2 | 2009 | 853 | 0.030 |
Why?
| Dilatation | 1 | 2014 | 60 | 0.030 |
Why?
| Risk Factors | 2 | 2019 | 8627 | 0.030 |
Why?
| Breast Neoplasms | 1 | 2004 | 1868 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2017 | 583 | 0.030 |
Why?
| Constriction, Pathologic | 1 | 2014 | 208 | 0.030 |
Why?
| Prosthesis Failure | 1 | 2014 | 117 | 0.030 |
Why?
| Specialization | 1 | 2013 | 114 | 0.030 |
Why?
| Glucocorticoids | 2 | 2010 | 532 | 0.020 |
Why?
| Anti-Inflammatory Agents | 2 | 2008 | 450 | 0.020 |
Why?
| Compassionate Use Trials | 1 | 2011 | 8 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 1477 | 0.020 |
Why?
| Blood Gas Analysis | 1 | 2009 | 72 | 0.020 |
Why?
| Critical Care | 1 | 2013 | 473 | 0.020 |
Why?
| Radiometry | 1 | 2008 | 42 | 0.020 |
Why?
| Pulmonary Circulation | 1 | 2009 | 406 | 0.020 |
Why?
| Immune System | 1 | 2008 | 173 | 0.020 |
Why?
| Exercise Test | 1 | 2009 | 544 | 0.020 |
Why?
| Iridium Radioisotopes | 1 | 2006 | 5 | 0.020 |
Why?
| Medical Oncology | 1 | 2008 | 229 | 0.020 |
Why?
| Respiratory Tract Neoplasms | 1 | 2006 | 2 | 0.020 |
Why?
| Administration, Inhalation | 1 | 2008 | 642 | 0.020 |
Why?
| Radiotherapy Dosage | 1 | 2006 | 245 | 0.020 |
Why?
| Papilloma | 1 | 2006 | 43 | 0.020 |
Why?
| Thoracic Neoplasms | 1 | 2006 | 32 | 0.020 |
Why?
| Injections | 1 | 2006 | 159 | 0.020 |
Why?
| Pilot Projects | 1 | 2009 | 1370 | 0.020 |
Why?
| Cells, Cultured | 2 | 2004 | 3890 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2010 | 1214 | 0.010 |
Why?
| Models, Statistical | 1 | 2008 | 604 | 0.010 |
Why?
| Secondary Prevention | 1 | 2006 | 222 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 935 | 0.010 |
Why?
| Bronchoalveolar Lavage | 1 | 2002 | 84 | 0.010 |
Why?
| Cohort Studies | 1 | 2011 | 4901 | 0.010 |
Why?
| Analysis of Variance | 1 | 2004 | 1226 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2012 | 3039 | 0.010 |
Why?
| Antigens, Plant | 1 | 2000 | 47 | 0.010 |
Why?
| Poaceae | 1 | 2000 | 65 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 1846 | 0.010 |
Why?
| Rats | 1 | 2008 | 4943 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 797 | 0.010 |
Why?
| Cell Culture Techniques | 1 | 2002 | 343 | 0.010 |
Why?
| Apoptosis | 1 | 2008 | 2369 | 0.010 |
Why?
| Blotting, Western | 1 | 2002 | 1151 | 0.010 |
Why?
| Dexamethasone | 1 | 2000 | 317 | 0.010 |
Why?
| Eosinophils | 1 | 2000 | 278 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2008 | 4409 | 0.010 |
Why?
| Kinetics | 1 | 2000 | 1550 | 0.010 |
Why?
| Case-Control Studies | 1 | 2004 | 3005 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 10463 | 0.010 |
Why?
| Macrophages | 1 | 2000 | 1261 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 17808 | 0.010 |
Why?
|
|
Musani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|